Skip to main content

Emergent BioSolutions Inc 10-Q for FY2021 Q2

Emergent BioSolutions Inc. (EBS)

10-Q 2021-07-30 For: 2021-06-30
View Original
Added on April 01, 2026

About this 10-Q

Emergent BioSolutions Inc filed this 10-Q on July 30, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).

Headline figures

Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$397.5M
up 0.7% from $394.7M a year earlier
Net income
$4.6M
down 95.0% from net income of $92.7M a year earlier
Diluted EPS
$0.09
down 94.8% from $1.73 a year earlier